A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

NCT01121731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection
Genotype 1
Treatment-Experienced Patients
Relapses

Interventions

DRUG: Interferon α-5
DRUG: Interferon-α5 plus Interferon-α 2b
DRUG: Interferon α-2b (INTRON® A)

Sponsor

Digna Biotech S.L.